Introduction:

rheumatic diseases are a group of about 250 conditions, mostly of a systemic nature that need periodic monitoring and adequate therapeutic control, pharmacological adherence is one of the main bases for the control of these conditions.

Objective:

determine pharmacological adherence in patients diagnosed with rheumatic diseases.

Method:

descriptive, cross-sectional study in 78 patients diagnosed with rheumatic diseases who attend the outpatient clinic of the Andean Hospital of Chimborazo. The Morisky Green test will be used to determine the therapeutic adherence and the questionnaire created by Bonilla and Gutierrez to identify the factors that negatively influence the pharmacological adherence of patients with these diseases.

Results:

mean age of 58.6 years, with a predominance of patients aged 60 years and over (44.87 %) and females (80.77 %). Osteoarthritis (44.87 %), rheumatoid arthritis (29.49 %) and fibromyalgia (19.23 %) were the most represented diseases. Patients with an evolution time between 1 and 4 years (47.44 %) predominated. 47.44 % of cases are not adherent, with patients with gout (80.00 %), osteoarthrosis (68.57 %) and fibromyalgia (66.67 %) standing out in this regard.

Conclusions:

there is a high percentage of patients with rheumatic disease who are not adherent with their pharmacological treatment, especially in those cases where bone deformities are not as visible as is the case of gout and fibromyalgia.

        · resumen en Español     · texto en Español     · Español ( pdf )